Difference between revisions of "MR Coordinating Committee"

From QIBA Wiki
Jump to navigation Jump to search
(Dr. Elsinger has stepped down from MR CC Co-chair role, so her name was removed)
Line 1: Line 1:
 
__NOTOC__
 
__NOTOC__
 
 
Co-Chairs: Michael Boss, PhD; Thomas L. Chenevert, PhD; Nandita deSouza, MD<br />RSNA Staff Support: Susan Stanfa
 
Co-Chairs: Michael Boss, PhD; Thomas L. Chenevert, PhD; Nandita deSouza, MD<br />RSNA Staff Support: Susan Stanfa
 
*[https://docs.google.com/spreadsheets/d/e/2PACX-1vReaE9KRKRnlwhq95r9wrvLzVcZMg5iehJatSFB4ZtrDgP99-Fg-kT1Mqiqhxj6IkUDgFqF-jItmXEO/pubhtml?gid=1050413002&single=true '''Roster''']
 
*[https://docs.google.com/spreadsheets/d/e/2PACX-1vReaE9KRKRnlwhq95r9wrvLzVcZMg5iehJatSFB4ZtrDgP99-Fg-kT1Mqiqhxj6IkUDgFqF-jItmXEO/pubhtml?gid=1050413002&single=true '''Roster''']

Revision as of 19:09, 2 March 2023

Co-Chairs: Michael Boss, PhD; Thomas L. Chenevert, PhD; Nandita deSouza, MD
RSNA Staff Support: Susan Stanfa

Scope

The MR Coordinating Committee is responsible for:

  • Monitoring and coordinating the activities of MR Biomarker Committees
  • Considering and proposing new candidate Biomarker Committees to the Steering Committee
  • Preparing/Reviewing and Prioritizing groundwork funding proposals for submission to the Steering Committee
  • Approving for publication Biomarker Profiles developed by the MR Biomarker Committees

Meetings

  • Tcons are held Quarterly. Contact RSNA Staff for details.